AIDS Vaccines

Displaying 1 - 4 of 4CSV
Reveiz, M., Xu, K., Lee, M., Wang, S., Olia, A. S., Harris, D. R., Liu, K., Liu, T., Schaub, A. J., Stephens, T., Wang, Y., Zhang, B., Huang, R., Tsybovsky, Y., Kwong, P. D., & Rawi, R. (2024). Vaccine-elicited and naturally elicited antibodies differ in their recognition of the HIV-1 fusion peptide. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1484029
Publication Date
Miner, M. D., deCamp, A., Grunenberg, N., De Rosa, S. C., Fiore-Gartland, A., Bar, K., Spearman, P., Allen, M., Yu, P.-C., Manso, B., Frahm, N., Kalams, S., Baden, L., Keefer, M. C., Scott, H. M., Novak, R., Van Tieu, H., Tomaras, G. D., Kublin, J. G., … Luke-Kilolam, A. (2024). Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial. EBioMedicine, 100, 104987. https://doi.org/10.1016/j.ebiom.2024.104987
Publication Date
Wang, S., Matassoli, F., Zhang, B., Liu, T., Shen, C.-H., Bylund, T., Johnston, T., Henry, A. R., Teng, I.-T., Tripathi, P., Becker, J. E., Changela, A., Chaudhary, R., Cheng, C., Gaudinski, M., Gorman, J., Harris, D. R., Lee, M., Morano, N. C., … Kwong, P. D. (2023). HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide. Cell Reports, 42(7), 112755. https://doi.org/10.1016/j.celrep.2023.112755
Publication Date
Xu, Y., Ferguson, T., Masuda, K., Siddiqui, M. A., Smith, K. P., Vest, O., Brooks, B., Zhou, Z., Obliosca, J., Kong, X.-P., Jiang, X., Yamashita, M., Moriya, T., & Tison, C. (2023). Short Carbon Nanotube-Based Delivery of mRNA for HIV-1 Vaccines. Biomolecules, 13(7), 1088. https://doi.org/10.3390/biom13071088
Publication Date